Featured Research

from universities, journals, and other organizations

Washington University Licenses New Antibacterial Technology

Date:
February 16, 1998
Source:
Washington University In St. Louis
Summary:
Washington University in St. Louis has signed an agreement with SIGA Pharmaceuticals Inc. that gives the company exclusive rights to new antibacterial technology. The agreement will allow SIGA to develop an entirely new class of antibiotics that are less likely to be sidelined by bacterial resistance than current therapies.

St. Louis, Feb. 11, 1998 -- Washington University in St. Louissigned an agreement today with SIGA Pharmaceuticals Inc. that gives thecompany exclusive rights to new antibacterial technology. The agreementwill allow SIGA to develop an entirely new class of antibiotics that areless likely to be sidelined by bacterial resistance than current therapies.It also provides three years of research funding to the WashingtonUniversity scientists who are involved in this project.

SIGA Pharmaceuticals is a New York-based drug development companythat produces vaccines, antibiotics and novel anti-infectives. It alsosigned agreements with MedImmune and Astra, two biotech companies thatpreviously had licensed the technology from Washington University.

"We are delighted to enter into a relationship with this excitingnew biopharmaceutical venture," says P. Andrew Neighbour, Ph.D., theUniversity's associate vice chancellor and director for technologymanagement. "We are optimistic that SIGA will develop effective new drugsfor the treatment ofGram-negative bacterial infections using this technology."

The technology was developed by Scott J. Hultgren, Ph.D., associateprofessor of molecular microbiology at the School of Medicine. Over thepast decade, Hultgren's group has determined how Gram-negative bacteriamanufacture the structures that allow them to cling to human tissues andtherefore cause disease. Gram-negative bacteria have an outer lipid layerand do not take up Gram stains.Most of Hultgren's work has focused on strains of E. coli thatinfect the kidney and bladder. But the same principles apply to many otherpathogens, including those that cause middle-ear infections, pneumonia,meningitis and gonorrhea.

"The knowledge that we generated by studying thestructure and function of microbial attachment has provided a blueprint forthe development of novel antimicrobial therapeutics and strategies,"Hultgren says.

E. coli is covered with hair-like structures called pili.The tips of the pili carry proteins that fit into receptors in the kidneyor bladder lining like keys into locks. Firmly anchored, the bacteria goabout their business undisturbed.Hultgren's team has identified the major components along the pilusassembly line. They include a protein that chaperones pilus subunits to theouter bacterial membrane and another that extrudes them to the cellsurface. The researchers also have identified compounds that may inhibitone of these proteins. With the SIGA funding, they now will develop andtest additional compounds. Such drugs should prevent Gram-negativepathogenic bacteria from making pili. The bald bacteria would be unable tocause disease.

"The mode of action of this new class of anti-infectives will beunlike any other previously discovered," Hultgren says. "This willcircumvent the resistance mechanisms already established in manyGram-negative bacteria. And because the pathway that makes pili isconserved in these microbes, inhibitors discovered by the SIGA/WashingtonUniversity collaboration have the potential to bebroad-spectrum antibiotics."


Story Source:

The above story is based on materials provided by Washington University In St. Louis. Note: Materials may be edited for content and length.


Cite This Page:

Washington University In St. Louis. "Washington University Licenses New Antibacterial Technology." ScienceDaily. ScienceDaily, 16 February 1998. <www.sciencedaily.com/releases/1998/02/980216075849.htm>.
Washington University In St. Louis. (1998, February 16). Washington University Licenses New Antibacterial Technology. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/1998/02/980216075849.htm
Washington University In St. Louis. "Washington University Licenses New Antibacterial Technology." ScienceDaily. www.sciencedaily.com/releases/1998/02/980216075849.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins